MCF-7 breast cancer cells transfected with protein kinase C-alpha exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype.
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Increased protein kinase C (PKC) activity in malignant breast tissue and positive correlations between PKC activity and expression of a more aggressive phenotype in breast cancer cell lines suggest a role for this signal transduction pathway in the pathogenesis and/or progression of breast cancer. To examine the role of PKC in the progression of breast cancer, human MCF-7 breast cancer cells were transfected with PKC-alpha, and a group of heterogenous cells stably overexpressing PKC-alpha were isolated (MCF-7-PKC-alpha). MCF-7-PKC-alpha cells expressed fivefold higher levels of PKC-alpha as compared to parental or vector-transfected MCF-7 cells. MCF-7-PKC-alpha cells also displayed a substantial increase in endogenous expression of PKC-beta and decreases in expression of the novel delta- and eta-PKC isoforms. MCF-7-PKC-alpha cells displayed an enhanced proliferative rate, anchorage-independent growth, dramatic morphologic alterations including loss of an epithelioid appearance, and increased tumorigenicity in nude mice. MCF-7-PKC-alpha cells exhibited a significant reduction in estrogen receptor expression and decreases in estrogen-dependent gene expression. These findings suggest that the PKC pathway may modulate progression of breast cancer to a more aggressive neoplastic process.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
The molecular heterogeneity of protein kinase C and its implications for cellular regulation
Nishizuka, Y. (1988) · Nature · doi:10.1038/334661a0 · Cited by 4,171
Disruption of epithelial cell-matrix interactions induces apoptosis
Frisch, S., & Francis, H. (1994) · The Journal of cell biology · doi:10.1083/jcb.124.4.619 · Cited by 3,254
Klein-Hitpaß, L., Schorpp, M., Wagner, U., & Ryffel, G. U. (1986) · Cell · doi:10.1016/0092-8674(86)90705-1 · Cited by 720
Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer.
Knight, W. A., Livingston, R. B., Gregory, E., & McGuire, W. L. (1977) · PubMed · Cited by 707
A secreted glycoprotein induced by estrogen in human breast cancer cell lines
Westley, B. (1980) · Cell · doi:10.1016/0092-8674(80)90621-2 · Cited by 479
A synthetic peptide substrate for selective assay of protein kinase C
Yasuda, I., Kishimoto, A., Tanaka, S.-I., Tominaga, M., Sakurai, A., & Nishizuka, Y. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)90996-z · Cited by 286
Protein kinase C — a family affair
Parker, P. J., Kour, G., Marais, R. M., Mitchell, F., Pears, C., Schaap, D., Stabel, S., & Webster, C. (1989) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(89)90159-7 · Cited by 284
Self-citationRio, M. C., Bellocq, J. P., Gairard, B., Rasmussen, U. B., Krust, A., Koehl, C., Calderoli, H., Schiff, V, Renaud, R., & Chambon, P. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.9243 · Cited by 278
The epsilon isoform of protein kinase C is an oncogene when overexpressed in rat fibroblasts.
Am, C., Guadagno, S. N., Rs, K., Fabbro, D., & Ib, W. (1993) · PubMed · Cited by 225
O'Brian, C. A., Vogel, V. G., Singletary, S. E., & Ward, N. E. (1989) · PubMed · Cited by 214
Philip, P. A., Rea, D., Thavasu, P., Carmichael, J., Stuart, N. S. A., Rockett, H., Talbot, D. C., Ganesan, T., Pettit, G. R., Balkwill, F., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.22.1812 · Cited by 187
Mutagenesis of the pseudosubstrate site of protein kinase C leads to activation
Pears, C. J., Kour, G., House, C. M., Kemp, B. E., & Parker, P. J. (1990) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1990.tb19431.x · Cited by 173
Self-citationBlobe, G. C., Sachs, C. W., Khan, W. A., Fabbro, D., Stabel, S., Wetsel, W. C., Obeid, L. M., Fine, R. L., & Hannun, Y. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54202-2 · Cited by 165
The role of cathepsin D in the invasiveness of human breast cancer cells.
Johnson, M. D., Torri, J. A., Lippman, M. E., & Dickson, R. B. (1993) · PubMed · Cited by 150
Vimentin—a new prognostic parameter in breast carcinoma?
Raymond, W. A., & Leong, A. S. ‐. (1989) · The Journal of Pathology · doi:10.1002/path.1711580205 · Cited by 145
A phase I study of intravenous bryostatin 1 in patients with advanced cancer
Prendiville, J., Crowther, D., Thatcher, N., Woll, P., Fox, B., McGown, A., Testa, N., Stern, P., McDermott, R., Potter, M., et al. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.352 · Cited by 145
Yu, G., Ahmad, S., Aquino, A., Fairchild, C. R., Trepel, J. B., Ohno, S., Suzuki, K., Tsuruo, T., Cowan, K. H., & Glazer, R. I. (1991) · Cancer Communications · doi:10.3727/095535491820873263 · Cited by 143
Seynaeve, C., Stetler‐Stevenson, M., Sebers, S., Kaur, G., Sausville, E. A., & Worland, P. J. (1993) · PubMed · Cited by 132
Bae, S.-N., Arand, G., Azzam, H. S., Pavasant, P., Torri, J. A., Frandsen, T. L., & Thompson, E. W. (1993) · Breast Cancer Research and Treatment · doi:10.1007/bf01833264 · Cited by 123
Osada, S., Hashimoto, Y., Nomura, S., Ohno, S., Chida, K., Tajima, O., Kubo, K., Akimoto, K., Koizumi, H., & Kitamura, Y. (1993) · PubMed · Cited by 107
Differential effects of bryostatin 1 and phorbol ester on human breast cancer cell lines.
Kennedy, M. J., Prestigiacomo, L. J., Tyler, G., May, W. S., & Davidson, N. E. (1992) · PubMed · Cited by 105
Raymond, W. A., & Leong, A. S.-Y. (1989) · The Journal of Pathology · doi:10.1002/path.1711570406 · Cited by 102
Tzukerman, M., Zhang, X.-K., & Pfahl, M. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-12-1983 · Cited by 98
Lee, S. A., Karaszkiewicz, J. W., & Anderson, W. B. (1992) · PubMed · Cited by 95
Saceda, M., Knabbe, C., Dickson, R. B., Lippman, M. E., Bronzert, D. A., Lindsey, R. K., Gottardis, M. M., & Martin, M. B. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55199-1 · Cited by 84
Issandou, M., Bayard, F., & Darbon, J. M. (1988) · PubMed · Cited by 71
McNeall, J., Sánchez, A., Gray, P. P., Chesterman, C. N., & Sleigh, M. J. (1989) · Gene · doi:10.1016/0378-1119(89)90010-3 · Cited by 37
Pietras, R. J., & Szego, C. M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199006073222313 · Cited by 32
Cited by
Protein kinase C and other diacylglycerol effectors in cancer
Griner, E. M., & Kazanietz, M. G. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2110 · Cited by 978
Protein kinase C isozymes and the regulation of diverse cell responses
Dempsey, E. C., Newton, A. C., Mochly-Rosen, D., Fields, A. P., Reyland, M. E., Insel, P. A., & Messing, R. O. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.279.3.l429 · Cited by 737
Giri, B., Dey, S., Das, T., Sarkar, M., Banerjee, J., & Dash, S. K. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.157 · Cited by 635
Cellular and Molecular Pharmacology of Antiestrogen Action and Resistance
Clarke, R., Leonessa, F., Welch, J. N., & Skaar, T. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01479-0 · Cited by 397
Gleave, M. E., & Monia, B. P. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1631 · Cited by 384
Metadata
- Authors
- Ways, D. K., Kukoly, C. A., deVente, J., Hooker, J. L., Bryant, W. O., Posekany, K. J., Fletcher, D. J., Cook, P. P., & Parker, P. J.
- Venue
- Journal of Clinical Investigation
- Published
- 1995-04-01
- Volume
- 95
- Issue
- 4
- Pages
- 1906-1915
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2106898231
- Cited by
- 266
- References
- 30
- FWCI
- 5.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.